Characterization of Molecular Features, Antigen-Binding, andin VitroProperties of IgG and IgM Variants of 4E10, an Anti-HIV Type 1 Neutralizing Monoclonal Antibody-Reference-Cited by-同舟云学术

Characterization of Molecular Features, Antigen-Binding, andin VitroProperties of IgG and IgM Variants of 4E10, an Anti-HIV Type 1 Neutralizing Monoclonal Antibody

Published:2004-07 Issue:7 Volume:20 Page:755-762
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Kunert Renate¹,Wolbank Susanne,Stiegler Gabriela,Weik Robert,Katinger Hermann

Affiliation:

1. Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences, A-1190 Vienna, Austria

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/0889222041524571

Reference34 articles.

1. Antibody neutralization and escape by HIV-1

2. Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells

3. A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1

4. Characterization of a Novel Human Immunodeficiency Virus Type 1 Neutralizable Epitope within the Immunodominant Region of gp41

5. Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposome-based peptide vaccines to elicit immune responses against the membrane active domains of the HIV-1 Env glycoprotein;Biochimica et Biophysica Acta (BBA) - Biomembranes;2024-01

2. Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile;iScience;2021-09

3. A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus;Immunity;2021-04

4. Coming together at the hinges: Therapeutic prospects of IgG3;mAbs;2021-01-01

5. Structure, Function, and Therapeutic Use of IgM Antibodies;Antibodies;2020-10-13